Copayment reductions generate greater medication adherence in targeted patients.
Journal Article (Journal Article)
A large value-based insurance design program offered by Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications. Our study showed that the program improved adherence to medications for diabetes, hypertension, hyperlipidemia, and congestive heart failure. We found that adherence improved for enrollees, ranging from a gain of 3.8 percentage points for patients with diabetes to 1.5 percentage points for those taking calcium-channel blockers, when compared to others whose employers did not offer a similar program. An examination of longer-term adherence and trends in health care spending is still needed to provide a compelling evidence base for value-based insurance design.
Full Text
Duke Authors
Cited Authors
- Maciejewski, ML; Farley, JF; Parker, J; Wansink, D
Published Date
- November 2010
Published In
Volume / Issue
- 29 / 11
Start / End Page
- 2002 - 2008
PubMed ID
- 21041739
Electronic International Standard Serial Number (EISSN)
- 1544-5208
Digital Object Identifier (DOI)
- 10.1377/hlthaff.2010.0571
Language
- eng
Conference Location
- United States